IL10 and neoplasm: Interestingly, elevated levels of IL-10 are frequently detected in the serum of cancer patients and correlate with poor prognosis [21]–[24], suggesting that IL-10 may contribute to immune suppression and protect tumor cells from cytotoxic T lymphocytes by down-regulation of class I and class II MHC.